These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 14652285

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. ERCC1 gene +262A/C polymorphism associated with risk of gastric cardiac adenocarcinoma in nonsmokers.
    Zhou RM, Niu CX, Wang N, Chen ZF, Lei SE, Li Y.
    Arch Med Res; 2012 Jan; 43(1):67-74. PubMed ID: 22374244
    [Abstract] [Full Text] [Related]

  • 25. Diets, polymorphisms of methylenetetrahydrofolate reductase, and the susceptibility of colon cancer and rectal cancer.
    Jiang Q, Chen K, Ma X, Li Q, Yu W, Shu G, Yao K.
    Cancer Detect Prev; 2005 Jan; 29(2):146-54. PubMed ID: 15829374
    [Abstract] [Full Text] [Related]

  • 26. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methionine synthase reductase (MTRR), and thymidylate synthase (TYMS) in multiple myeloma risk.
    Lima CS, Ortega MM, Ozelo MC, Araujo RC, De Souza CA, Lorand-Metze I, Annichino-Bizzacchi JM, Costa FF.
    Leuk Res; 2008 Mar; 32(3):401-5. PubMed ID: 17655928
    [Abstract] [Full Text] [Related]

  • 27. Methylenetetrahydrofolate reductase genotype affects risk of relapse after hematopoietic cell transplantation for chronic myelogenous leukemia.
    Robien K, Ulrich CM, Bigler J, Yasui Y, Gooley T, Bruemmer B, Potter JD, Radich JP.
    Clin Cancer Res; 2004 Nov 15; 10(22):7592-8. PubMed ID: 15569990
    [Abstract] [Full Text] [Related]

  • 28. Impact of methylenetetrahydrofolate reductase (MTHFR) codon (677) and methionine synthase (MS) codon (2756) on risk of cervical carcinogenesis in North Indian population.
    Shekari M, Sobti RC, Kordi Tamandani DM, Suri V.
    Arch Gynecol Obstet; 2008 Dec 15; 278(6):517-24. PubMed ID: 18351371
    [Abstract] [Full Text] [Related]

  • 29. Alcohol drinking and one-carbon metabolism-related gene polymorphisms on pancreatic cancer risk.
    Suzuki T, Matsuo K, Sawaki A, Mizuno N, Hiraki A, Kawase T, Watanabe M, Nakamura T, Yamao K, Tajima K, Tanaka H.
    Cancer Epidemiol Biomarkers Prev; 2008 Oct 15; 17(10):2742-7. PubMed ID: 18843018
    [Abstract] [Full Text] [Related]

  • 30. Genetic polymorphisms of glutathione S-transferase genes GSTP1, GSTM1, and GSTT1 and risk of esophageal and gastric cardia cancers.
    Zendehdel K, Bahmanyar S, McCarthy S, Nyren O, Andersson B, Ye W.
    Cancer Causes Control; 2009 Dec 15; 20(10):2031-8. PubMed ID: 19618282
    [Abstract] [Full Text] [Related]

  • 31. Selenium status and the risk of esophageal and gastric cancer subtypes: the Netherlands cohort study.
    Steevens J, van den Brandt PA, Goldbohm RA, Schouten LJ.
    Gastroenterology; 2010 May 15; 138(5):1704-13. PubMed ID: 20006613
    [Abstract] [Full Text] [Related]

  • 32. [Correlation of aberrant methylation of MGMT gene to MTHFR C677T genetic polymorphisms in esophageal squamous cell carcinoma].
    Xue HC, Wang JM, Xu B, Guo GP, Hua ZL, Zhou Q, Zhu ZH, Ma ZK, Gao J.
    Ai Zheng; 2008 Dec 15; 27(12):1256-62. PubMed ID: 19079989
    [Abstract] [Full Text] [Related]

  • 33. Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma.
    Kim HN, Lee IK, Kim YK, Tran HT, Yang DH, Lee JJ, Shin MH, Park KS, Shin MG, Choi JS, Kim HJ.
    Br J Haematol; 2008 Feb 15; 140(3):287-94. PubMed ID: 18042267
    [Abstract] [Full Text] [Related]

  • 34. Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage.
    Botto N, Andreassi MG, Manfredi S, Masetti S, Cocci F, Colombo MG, Storti S, Rizza A, Biagini A.
    Eur J Hum Genet; 2003 Sep 15; 11(9):671-8. PubMed ID: 12939653
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Association between polymorphisms of folate-metabolizing enzymes and risk of prostate cancer.
    Marchal C, Redondo M, Reyes-Engel A, Perea-Milla E, Gaitan MJ, Machuca J, Diaz F, Caballero J, Carnero J.
    Eur J Surg Oncol; 2008 Jul 15; 34(7):805-10. PubMed ID: 17967524
    [Abstract] [Full Text] [Related]

  • 37. No association between MTHFR A1298C and MTRR A66G polymorphisms, and MS in an Australian cohort.
    Szvetko AL, Fowdar J, Nelson J, Colson N, Tajouri L, Csurhes PA, Pender MP, Griffiths LR.
    J Neurol Sci; 2007 Jan 15; 252(1):49-52. PubMed ID: 17113603
    [Abstract] [Full Text] [Related]

  • 38. [A case-control study on the polymorphisms of methylenetetrahydrofolate reductase 1298A-->C and susceptibility of esophageal cancer].
    Gao CM, Toshiro T, Wu JZ, Cao HX, Liu YT, Ding JH, Li SP, Su P, Hu X, Kai HT, Kazuo T.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Apr 15; 25(4):341-5. PubMed ID: 15231206
    [Abstract] [Full Text] [Related]

  • 39. 5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer.
    Li D, Ahmed M, Li Y, Jiao L, Chou TH, Wolff RA, Lenzi R, Evans DB, Bondy ML, Pisters PW, Abbruzzese JL, Hassan MM.
    Cancer Epidemiol Biomarkers Prev; 2005 Jun 15; 14(6):1470-6. PubMed ID: 15941958
    [Abstract] [Full Text] [Related]

  • 40. Folate metabolism polymorphisms influence risk of colorectal adenoma recurrence.
    Hubner RA, Muir KR, Liu JF, Sellick GS, Logan RF, Grainge M, Armitage N, Chau I, Houlston RS.
    Cancer Epidemiol Biomarkers Prev; 2006 Sep 15; 15(9):1607-13. PubMed ID: 16985020
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.